Literature DB >> 23098685

Inhaler competence in asthma: common errors, barriers to use and recommended solutions.

D Price, S Bosnic-Anticevich, A Briggs, H Chrystyn, C Rand, G Scheuch, J Bousquet.   

Abstract

Whilst the inhaled route is the first line administration method in the management of asthma, it is well documented that patients can have problems adopting the correct inhaler technique and thus receiving adequate medication. This applies equally to metered dose inhalers and dry powder inhalers and leads to poor disease control and increased healthcare costs. Reviews have highlighted these problems and the recent European Consensus Statement developed a call to action to seek solutions. This review takes forward the challenge of inhaler competence by highlighting the issues and suggesting potential solutions to these problems. The opportunity for technological innovation and educational interventions to reduce errors is highlighted, as well as the specific challenges faced by children. This review is intended as a policy document, as most issues faced by patients have not changed for half a century, and this situation should not be allowed to continue any longer. Future direction with respect to research, policy needs and practice, together with education requirements in inhaler technique are described.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098685     DOI: 10.1016/j.rmed.2012.09.017

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  93 in total

Review 1.  Advances in metered dose inhaler technology: hardware development.

Authors:  Stephen W Stein; Poonam Sheth; P David Hodson; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2013-12-20       Impact factor: 3.246

Review 2.  A path to successful patient outcomes through aerosol drug delivery to children: a narrative review.

Authors:  Arzu Ari
Journal:  Ann Transl Med       Date:  2021-04

3.  Factors Determining In Vitro Lung Deposition of Albuterol Aerosol Delivered by Ventolin Metered-Dose Inhaler.

Authors:  Rajoshi Biswas; Nicola A Hanania; Ashutosh Sabharwal
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2017-02-03       Impact factor: 2.849

Review 4.  Severe asthma in school-age children: evaluation and phenotypic advances.

Authors:  Andrea Coverstone; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

5.  Real-world asthma management with inhaler devices in Switzerland-results of the asthma survey.

Authors:  Christian F Clarenbach; Laurent P Nicod; Malcolm Kohler
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

6.  Barriers to medication use in rural underserved patients with asthma.

Authors:  Henry N Young; Shada Kanchanasuwan; Elizabeth D Cox; Megan M Moreno; Nadra S Havican
Journal:  Res Social Adm Pharm       Date:  2014-12-23

7.  Can a Short Video Improve Inhaler Use in Urban Youth?

Authors:  Sara Brown; Victoria Tutag Lehr; Nathan French; Christopher Alan Giuliano
Journal:  J Pediatr Pharmacol Ther       Date:  2017 Jul-Aug

8.  Suboptimal inhaler medication adherence and incorrect technique are common among chronic obstructive pulmonary disease patients.

Authors:  Krishna B Sriram; Matthew Percival
Journal:  Chron Respir Dis       Date:  2015-09-22       Impact factor: 2.444

9.  Study of inhaler technique in asthma patients: differences between pediatric and adult patients.

Authors:  Pablo Manríquez; Ana María Acuña; Luis Muñoz; Alvaro Reyes
Journal:  J Bras Pneumol       Date:  2015 Sep-Oct       Impact factor: 2.624

10.  Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.

Authors:  Thomas Voshaar; Monica Spinola; Patrick Linnane; Alice Campanini; Daniel Lock; Anthony Lafratta; Mario Scuri; Barbara Ronca; Andrea S Melani
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2013-12-03       Impact factor: 2.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.